The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global General Anaesthetics Market Research Report 2024
Synopsis
General Anesthesia Drugs, also known as general anaesthetics, is a kind of drug that can inhibit the central nervous system function, make the consciousness, feeling and reflection temporarily disappeared, skeletal muscle relaxation, mainly used for anesthesia before surgery.
The global General Anaesthetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Anaesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthetics.
Report Scope
The General Anaesthetics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anaesthetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anaesthetics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astrazeneca
Fresenius-Kabi
Abbott
Bayer
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Lunan
Humanwell Healthcare
Nhwa Pharmaceutical
Guangdong Jiabo Pharmaceutical
Sichuan Guorui Pharmaceutical
Xi'an Libang Pharmaceutical
Sichuan Kelun Pharmaceutical
Hengrui Pharmaceutical
Shanghai United Imaging Healthcare
Wandong Medical Technology
Segment by Type
by Drug Type
Propofol
Sevoflurane
Etomidate
Midazolam
Isoflurane
Other
by Delivery Drug Way
Intravenous Anesthetics
Inhalational Anesthetics
Segment by Application
Emergency Room
Operating Room
ICU
Surgical
Oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Anaesthetics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
General Anesthesia Drugs, also known as general anaesthetics, is a kind of drug that can inhibit the central nervous system function, make the consciousness, feeling and reflection temporarily disappeared, skeletal muscle relaxation, mainly used for anesthesia before surgery.
The global General Anaesthetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Anaesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthetics.
Report Scope
The General Anaesthetics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anaesthetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anaesthetics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astrazeneca
Fresenius-Kabi
Abbott
Bayer
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Lunan
Humanwell Healthcare
Nhwa Pharmaceutical
Guangdong Jiabo Pharmaceutical
Sichuan Guorui Pharmaceutical
Xi'an Libang Pharmaceutical
Sichuan Kelun Pharmaceutical
Hengrui Pharmaceutical
Shanghai United Imaging Healthcare
Wandong Medical Technology
Segment by Type
by Drug Type
Propofol
Sevoflurane
Etomidate
Midazolam
Isoflurane
Other
by Delivery Drug Way
Intravenous Anesthetics
Inhalational Anesthetics
Segment by Application
Emergency Room
Operating Room
ICU
Surgical
Oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Anaesthetics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Drug Type
1.2.1 Global General Anaesthetics Market Size Growth Rate by Drug Type: 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Etomidate
1.2.5 Midazolam
1.2.6 Isoflurane
1.2.7 Other
1.3 Market by Application
1.3.1 Global General Anaesthetics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Emergency Room
1.3.3 Operating Room
1.3.4 ICU
1.3.5 Surgical
1.3.6 Oncology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthetics Market Perspective (2019-2030)
2.2 General Anaesthetics Growth Trends by Region
2.2.1 Global General Anaesthetics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 General Anaesthetics Historic Market Size by Region (2019-2024)
2.2.3 General Anaesthetics Forecasted Market Size by Region (2025-2030)
2.3 General Anaesthetics Market Dynamics
2.3.1 General Anaesthetics Industry Trends
2.3.2 General Anaesthetics Market Drivers
2.3.3 General Anaesthetics Market Challenges
2.3.4 General Anaesthetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthetics Players by Revenue
3.1.1 Global Top General Anaesthetics Players by Revenue (2019-2024)
3.1.2 Global General Anaesthetics Revenue Market Share by Players (2019-2024)
3.2 Global General Anaesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthetics Revenue
3.4 Global General Anaesthetics Market Concentration Ratio
3.4.1 Global General Anaesthetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthetics Revenue in 2023
3.5 General Anaesthetics Key Players Head office and Area Served
3.6 Key Players General Anaesthetics Product Solution and Service
3.7 Date of Enter into General Anaesthetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthetics Breakdown Data by Type
4.1 Global General Anaesthetics Historic Market Size by Type (2019-2024)
4.2 Global General Anaesthetics Forecasted Market Size by Type (2025-2030)
5 General Anaesthetics Breakdown Data by Application
5.1 Global General Anaesthetics Historic Market Size by Application (2019-2024)
5.2 Global General Anaesthetics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America General Anaesthetics Market Size (2019-2030)
6.2 North America General Anaesthetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America General Anaesthetics Market Size by Country (2019-2024)
6.4 North America General Anaesthetics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anaesthetics Market Size (2019-2030)
7.2 Europe General Anaesthetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe General Anaesthetics Market Size by Country (2019-2024)
7.4 Europe General Anaesthetics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthetics Market Size (2019-2030)
8.2 Asia-Pacific General Anaesthetics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific General Anaesthetics Market Size by Region (2019-2024)
8.4 Asia-Pacific General Anaesthetics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anaesthetics Market Size (2019-2030)
9.2 Latin America General Anaesthetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America General Anaesthetics Market Size by Country (2019-2024)
9.4 Latin America General Anaesthetics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthetics Market Size (2019-2030)
10.2 Middle East & Africa General Anaesthetics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa General Anaesthetics Market Size by Country (2019-2024)
10.4 Middle East & Africa General Anaesthetics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Detail
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca General Anaesthetics Introduction
11.1.4 Astrazeneca Revenue in General Anaesthetics Business (2019-2024)
11.1.5 Astrazeneca Recent Development
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Detail
11.2.2 Fresenius-Kabi Business Overview
11.2.3 Fresenius-Kabi General Anaesthetics Introduction
11.2.4 Fresenius-Kabi Revenue in General Anaesthetics Business (2019-2024)
11.2.5 Fresenius-Kabi Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott General Anaesthetics Introduction
11.3.4 Abbott Revenue in General Anaesthetics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer General Anaesthetics Introduction
11.4.4 Bayer Revenue in General Anaesthetics Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie General Anaesthetics Introduction
11.5.4 AbbVie Revenue in General Anaesthetics Business (2019-2024)
11.5.5 AbbVie Recent Development
11.6 Baxter Healthcare
11.6.1 Baxter Healthcare Company Detail
11.6.2 Baxter Healthcare Business Overview
11.6.3 Baxter Healthcare General Anaesthetics Introduction
11.6.4 Baxter Healthcare Revenue in General Anaesthetics Business (2019-2024)
11.6.5 Baxter Healthcare Recent Development
11.7 B.Braun
11.7.1 B.Braun Company Detail
11.7.2 B.Braun Business Overview
11.7.3 B.Braun General Anaesthetics Introduction
11.7.4 B.Braun Revenue in General Anaesthetics Business (2019-2024)
11.7.5 B.Braun Recent Development
11.8 Maruishi
11.8.1 Maruishi Company Detail
11.8.2 Maruishi Business Overview
11.8.3 Maruishi General Anaesthetics Introduction
11.8.4 Maruishi Revenue in General Anaesthetics Business (2019-2024)
11.8.5 Maruishi Recent Development
11.9 Piramal
11.9.1 Piramal Company Detail
11.9.2 Piramal Business Overview
11.9.3 Piramal General Anaesthetics Introduction
11.9.4 Piramal Revenue in General Anaesthetics Business (2019-2024)
11.9.5 Piramal Recent Development
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Detail
11.10.2 Hikma Pharmaceuticals Business Overview
11.10.3 Hikma Pharmaceuticals General Anaesthetics Introduction
11.10.4 Hikma Pharmaceuticals Revenue in General Anaesthetics Business (2019-2024)
11.10.5 Hikma Pharmaceuticals Recent Development
11.11 Mylan
11.11.1 Mylan Company Detail
11.11.2 Mylan Business Overview
11.11.3 Mylan General Anaesthetics Introduction
11.11.4 Mylan Revenue in General Anaesthetics Business (2019-2024)
11.11.5 Mylan Recent Development
11.12 Lunan
11.12.1 Lunan Company Detail
11.12.2 Lunan Business Overview
11.12.3 Lunan General Anaesthetics Introduction
11.12.4 Lunan Revenue in General Anaesthetics Business (2019-2024)
11.12.5 Lunan Recent Development
11.13 Humanwell Healthcare
11.13.1 Humanwell Healthcare Company Detail
11.13.2 Humanwell Healthcare Business Overview
11.13.3 Humanwell Healthcare General Anaesthetics Introduction
11.13.4 Humanwell Healthcare Revenue in General Anaesthetics Business (2019-2024)
11.13.5 Humanwell Healthcare Recent Development
11.14 Nhwa Pharmaceutical
11.14.1 Nhwa Pharmaceutical Company Detail
11.14.2 Nhwa Pharmaceutical Business Overview
11.14.3 Nhwa Pharmaceutical General Anaesthetics Introduction
11.14.4 Nhwa Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.14.5 Nhwa Pharmaceutical Recent Development
11.15 Guangdong Jiabo Pharmaceutical
11.15.1 Guangdong Jiabo Pharmaceutical Company Detail
11.15.2 Guangdong Jiabo Pharmaceutical Business Overview
11.15.3 Guangdong Jiabo Pharmaceutical General Anaesthetics Introduction
11.15.4 Guangdong Jiabo Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.15.5 Guangdong Jiabo Pharmaceutical Recent Development
11.16 Sichuan Guorui Pharmaceutical
11.16.1 Sichuan Guorui Pharmaceutical Company Detail
11.16.2 Sichuan Guorui Pharmaceutical Business Overview
11.16.3 Sichuan Guorui Pharmaceutical General Anaesthetics Introduction
11.16.4 Sichuan Guorui Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.16.5 Sichuan Guorui Pharmaceutical Recent Development
11.17 Xi'an Libang Pharmaceutical
11.17.1 Xi'an Libang Pharmaceutical Company Detail
11.17.2 Xi'an Libang Pharmaceutical Business Overview
11.17.3 Xi'an Libang Pharmaceutical General Anaesthetics Introduction
11.17.4 Xi'an Libang Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.17.5 Xi'an Libang Pharmaceutical Recent Development
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Detail
11.18.2 Sichuan Kelun Pharmaceutical Business Overview
11.18.3 Sichuan Kelun Pharmaceutical General Anaesthetics Introduction
11.18.4 Sichuan Kelun Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.18.5 Sichuan Kelun Pharmaceutical Recent Development
11.19 Hengrui Pharmaceutical
11.19.1 Hengrui Pharmaceutical Company Detail
11.19.2 Hengrui Pharmaceutical Business Overview
11.19.3 Hengrui Pharmaceutical General Anaesthetics Introduction
11.19.4 Hengrui Pharmaceutical Revenue in General Anaesthetics Business (2019-2024)
11.19.5 Hengrui Pharmaceutical Recent Development
11.20 Shanghai United Imaging Healthcare
11.20.1 Shanghai United Imaging Healthcare Company Detail
11.20.2 Shanghai United Imaging Healthcare Business Overview
11.20.3 Shanghai United Imaging Healthcare General Anaesthetics Introduction
11.20.4 Shanghai United Imaging Healthcare Revenue in General Anaesthetics Business (2019-2024)
11.20.5 Shanghai United Imaging Healthcare Recent Development
11.21 Wandong Medical Technology
11.21.1 Wandong Medical Technology Company Detail
11.21.2 Wandong Medical Technology Business Overview
11.21.3 Wandong Medical Technology General Anaesthetics Introduction
11.21.4 Wandong Medical Technology Revenue in General Anaesthetics Business (2019-2024)
11.21.5 Wandong Medical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global General Anaesthetics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Propofol
Table 3. Key Players of Sevoflurane
Table 4. Key Players of Etomidate
Table 5. Key Players of Midazolam
Table 6. Key Players of Isoflurane
Table 7. Key Players of Other
Table 8. Global General Anaesthetics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global General Anaesthetics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global General Anaesthetics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global General Anaesthetics Market Share by Region (2019-2024)
Table 12. Global General Anaesthetics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global General Anaesthetics Market Share by Region (2025-2030)
Table 14. General Anaesthetics Market Trends
Table 15. General Anaesthetics Market Drivers
Table 16. General Anaesthetics Market Challenges
Table 17. General Anaesthetics Market Restraints
Table 18. Global General Anaesthetics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global General Anaesthetics Market Share by Players (2019-2024)
Table 20. Global Top General Anaesthetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetics as of 2023)
Table 21. Ranking of Global Top General Anaesthetics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by General Anaesthetics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players General Anaesthetics Product Solution and Service
Table 25. Date of Enter into General Anaesthetics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global General Anaesthetics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global General Anaesthetics Revenue Market Share by Type (2019-2024)
Table 29. Global General Anaesthetics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global General Anaesthetics Revenue Market Share by Type (2025-2030)
Table 31. Global General Anaesthetics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global General Anaesthetics Revenue Market Share by Application (2019-2024)
Table 33. Global General Anaesthetics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global General Anaesthetics Revenue Market Share by Application (2025-2030)
Table 35. North America General Anaesthetics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America General Anaesthetics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America General Anaesthetics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe General Anaesthetics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe General Anaesthetics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe General Anaesthetics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific General Anaesthetics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific General Anaesthetics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific General Anaesthetics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America General Anaesthetics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America General Anaesthetics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America General Anaesthetics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa General Anaesthetics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa General Anaesthetics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa General Anaesthetics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Astrazeneca Company Detail
Table 51. Astrazeneca Business Overview
Table 52. Astrazeneca General Anaesthetics Product
Table 53. Astrazeneca Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 54. Astrazeneca Recent Development
Table 55. Fresenius-Kabi Company Detail
Table 56. Fresenius-Kabi Business Overview
Table 57. Fresenius-Kabi General Anaesthetics Product
Table 58. Fresenius-Kabi Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 59. Fresenius-Kabi Recent Development
Table 60. Abbott Company Detail
Table 61. Abbott Business Overview
Table 62. Abbott General Anaesthetics Product
Table 63. Abbott Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 64. Abbott Recent Development
Table 65. Bayer Company Detail
Table 66. Bayer Business Overview
Table 67. Bayer General Anaesthetics Product
Table 68. Bayer Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. AbbVie Company Detail
Table 71. AbbVie Business Overview
Table 72. AbbVie General Anaesthetics Product
Table 73. AbbVie Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Baxter Healthcare Company Detail
Table 76. Baxter Healthcare Business Overview
Table 77. Baxter Healthcare General Anaesthetics Product
Table 78. Baxter Healthcare Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 79. Baxter Healthcare Recent Development
Table 80. B.Braun Company Detail
Table 81. B.Braun Business Overview
Table 82. B.Braun General Anaesthetics Product
Table 83. B.Braun Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 84. B.Braun Recent Development
Table 85. Maruishi Company Detail
Table 86. Maruishi Business Overview
Table 87. Maruishi General Anaesthetics Product
Table 88. Maruishi Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 89. Maruishi Recent Development
Table 90. Piramal Company Detail
Table 91. Piramal Business Overview
Table 92. Piramal General Anaesthetics Product
Table 93. Piramal Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 94. Piramal Recent Development
Table 95. Hikma Pharmaceuticals Company Detail
Table 96. Hikma Pharmaceuticals Business Overview
Table 97. Hikma Pharmaceuticals General Anaesthetics Product
Table 98. Hikma Pharmaceuticals Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 99. Hikma Pharmaceuticals Recent Development
Table 100. Mylan Company Detail
Table 101. Mylan Business Overview
Table 102. Mylan General Anaesthetics Product
Table 103. Mylan Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 104. Mylan Recent Development
Table 105. Lunan Company Detail
Table 106. Lunan Business Overview
Table 107. Lunan General Anaesthetics Product
Table 108. Lunan Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 109. Lunan Recent Development
Table 110. Humanwell Healthcare Company Detail
Table 111. Humanwell Healthcare Business Overview
Table 112. Humanwell Healthcare General Anaesthetics Product
Table 113. Humanwell Healthcare Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 114. Humanwell Healthcare Recent Development
Table 115. Nhwa Pharmaceutical Company Detail
Table 116. Nhwa Pharmaceutical Business Overview
Table 117. Nhwa Pharmaceutical General Anaesthetics Product
Table 118. Nhwa Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 119. Nhwa Pharmaceutical Recent Development
Table 120. Guangdong Jiabo Pharmaceutical Company Detail
Table 121. Guangdong Jiabo Pharmaceutical Business Overview
Table 122. Guangdong Jiabo Pharmaceutical General Anaesthetics Product
Table 123. Guangdong Jiabo Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 124. Guangdong Jiabo Pharmaceutical Recent Development
Table 125. Sichuan Guorui Pharmaceutical Company Detail
Table 126. Sichuan Guorui Pharmaceutical Business Overview
Table 127. Sichuan Guorui Pharmaceutical General Anaesthetics Product
Table 128. Sichuan Guorui Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 129. Sichuan Guorui Pharmaceutical Recent Development
Table 130. Xi'an Libang Pharmaceutical Company Detail
Table 131. Xi'an Libang Pharmaceutical Business Overview
Table 132. Xi'an Libang Pharmaceutical General Anaesthetics Product
Table 133. Xi'an Libang Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 134. Xi'an Libang Pharmaceutical Recent Development
Table 135. Sichuan Kelun Pharmaceutical Company Detail
Table 136. Sichuan Kelun Pharmaceutical Business Overview
Table 137. Sichuan Kelun Pharmaceutical General Anaesthetics Product
Table 138. Sichuan Kelun Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 139. Sichuan Kelun Pharmaceutical Recent Development
Table 140. Hengrui Pharmaceutical Company Detail
Table 141. Hengrui Pharmaceutical Business Overview
Table 142. Hengrui Pharmaceutical General Anaesthetics Product
Table 143. Hengrui Pharmaceutical Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 144. Hengrui Pharmaceutical Recent Development
Table 145. Shanghai United Imaging Healthcare Company Detail
Table 146. Shanghai United Imaging Healthcare Business Overview
Table 147. Shanghai United Imaging Healthcare General Anaesthetics Product
Table 148. Shanghai United Imaging Healthcare Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 149. Shanghai United Imaging Healthcare Recent Development
Table 150. Wandong Medical Technology Company Detail
Table 151. Wandong Medical Technology Business Overview
Table 152. Wandong Medical Technology General Anaesthetics Product
Table 153. Wandong Medical Technology Revenue in General Anaesthetics Business (2019-2024) & (US$ Million)
Table 154. Wandong Medical Technology Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Anaesthetics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global General Anaesthetics Market Share by Type: 2023 VS 2030
Figure 3. Propofol Features
Figure 4. Sevoflurane Features
Figure 5. Etomidate Features
Figure 6. Midazolam Features
Figure 7. Isoflurane Features
Figure 8. Other Features
Figure 9. Global General Anaesthetics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global General Anaesthetics Market Share by Application: 2023 VS 2030
Figure 11. Emergency Room Case Studies
Figure 12. Operating Room Case Studies
Figure 13. ICU Case Studies
Figure 14. Surgical Case Studies
Figure 15. Oncology Case Studies
Figure 16. General Anaesthetics Report Years Considered
Figure 17. Global General Anaesthetics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global General Anaesthetics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global General Anaesthetics Market Share by Region: 2023 VS 2030
Figure 20. Global General Anaesthetics Market Share by Players in 2023
Figure 21. Global Top General Anaesthetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthetics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by General Anaesthetics Revenue in 2023
Figure 23. North America General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America General Anaesthetics Market Share by Country (2019-2030)
Figure 25. United States General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe General Anaesthetics Market Share by Country (2019-2030)
Figure 29. Germany General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific General Anaesthetics Market Share by Region (2019-2030)
Figure 37. China General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America General Anaesthetics Market Share by Country (2019-2030)
Figure 45. Mexico General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa General Anaesthetics Market Share by Country (2019-2030)
Figure 49. Turkey General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia General Anaesthetics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Astrazeneca Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 52. Fresenius-Kabi Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 53. Abbott Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 54. Bayer Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 55. AbbVie Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 56. Baxter Healthcare Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 57. B.Braun Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 58. Maruishi Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 59. Piramal Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 61. Mylan Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 62. Lunan Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 63. Humanwell Healthcare Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 64. Nhwa Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 65. Guangdong Jiabo Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 66. Sichuan Guorui Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 67. Xi'an Libang Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 68. Sichuan Kelun Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 69. Hengrui Pharmaceutical Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 70. Shanghai United Imaging Healthcare Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 71. Wandong Medical Technology Revenue Growth Rate in General Anaesthetics Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
